BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24607015)

  • 1. Worksite health and wellness in the European union.
    Guazzi M; Faggiano P; Mureddu GF; Faden G; Niebauer J; Temporelli PL
    Prog Cardiovasc Dis; 2014; 56(5):508-14. PubMed ID: 24607015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worksite health and wellness programs: Canadian achievements & prospects.
    Després JP; Alméras N; Gauvin L
    Prog Cardiovasc Dis; 2014; 56(5):484-92. PubMed ID: 24607012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease prevention and implications for worksite health promotion programs in Brazil.
    Cipriano G; Neves LM; Cipriano GF; Chiappa GR; Borghi-Silva A
    Prog Cardiovasc Dis; 2014; 56(5):493-500. PubMed ID: 24607013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worksite health and wellness programs in India.
    Babu AS; Madan K; Veluswamy SK; Mehra R; Maiya AG
    Prog Cardiovasc Dis; 2014; 56(5):501-7. PubMed ID: 24607014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current trends in reducing cardiovascular risk factors in the United States: focus on worksite health and wellness.
    Cahalin LP; Myers J; Kaminsky L; Briggs P; Forman DE; Patel MJ; Pinkstaff SO; Arena R
    Prog Cardiovasc Dis; 2014; 56(5):476-83. PubMed ID: 24607011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle modification interventions and cardiovascular health: global perspectives on worksite health and wellness and cardiac rehabilitation.
    Arena R
    Prog Cardiovasc Dis; 2014; 56(5):473-5. PubMed ID: 24607010
    [No Abstract]   [Full Text] [Related]  

  • 7. Worksite wellness for the primary and secondary prevention of cardiovascular disease in Japan: the current delivery system and future directions.
    Okamura T; Sugiyama D; Tanaka T; Dohi S
    Prog Cardiovasc Dis; 2014; 56(5):515-21. PubMed ID: 24607016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac rehabilitation in Europe.
    Humphrey R; Guazzi M; Niebauer J
    Prog Cardiovasc Dis; 2014; 56(5):551-6. PubMed ID: 24607021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The worksite as an asset for promoting health in Europe. Final results of the MoveEurope campaign.
    Masanotti G
    Ig Sanita Pubbl; 2014; 70(2):185-96. PubMed ID: 25008224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Workplace health promotion program quality evaluation questionnaire].
    Korzeniowska E; Puchalski K
    Med Pr; 2002; 53(5):361-8. PubMed ID: 12577802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Workplace wellness recognition for optimizing workplace health: a presidential advisory from the American Heart Association.
    Fonarow GC; Calitz C; Arena R; Baase C; Isaac FW; Lloyd-Jones D; Peterson ED; Pronk N; Sanchez E; Terry PE; Volpp KG; Antman EM;
    Circulation; 2015 May; 131(20):e480-97. PubMed ID: 25869199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge for preventive cardiology.
    Kotseva K; Wood D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S19-23. PubMed ID: 19675431
    [No Abstract]   [Full Text] [Related]  

  • 13. Ferrari Corporate Wellness Program: Results of a Pilot Analysis and the "Drag" Impact in the Workplace.
    Biffi A; Fernando F; Adami PE; Messina M; Sirico F; Di Paolo F; Coluccia R; Borghi C; D'Ascenzi F; Volpe M
    High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):261-266. PubMed ID: 29956111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The history and impact of worksite wellness.
    Reardon J
    Nurs Econ; 1998; 16(3):117-21. PubMed ID: 9748973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a worksite wellness program designed to reduce cardiovascular risks.
    Roblin DW; Robinson BE; Benjamin SA
    J Ambul Care Manage; 2013; 36(4):272-9. PubMed ID: 24402067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A worksite intervention to reduce the cardiovascular risk: proposal of a study design easy to integrate within Italian organization of occupational health surveillance.
    Mastrangelo G; Marangi G; Bontadi D; Fadda E; Cegolon L; Bortolotto M; Fedeli U; Marchiori L
    BMC Public Health; 2015 Jan; 15():12. PubMed ID: 25604904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving the worksite health promotion profession forward: is the time right for requiring standards? A review of the literature.
    Watkins C; English G
    Health Promot Pract; 2015 Jan; 16(1):20-7. PubMed ID: 25125551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Implementation of Worksite Health and Wellness Programs: A Focus on Non-Communicable Disease.
    Cahalin LP; Kaminsky L; Lavie CJ; Briggs P; Cahalin BL; Myers J; Forman DE; Patel MJ; Pinkstaff SO; Arena R
    Prog Cardiovasc Dis; 2015; 58(1):94-101. PubMed ID: 25936908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and management of the workplace for CVD risk.
    Nowack KM; Schnall P; Melamed S; Froom P; Fisher J; Belkić K
    Occup Med; 2000; 15(1):231-56. PubMed ID: 10702088
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of a worksite intervention program on cardiovascular risk factors: a demonstration project in an Indian industrial population.
    Prabhakaran D; Jeemon P; Goenka S; Lakshmy R; Thankappan KR; Ahmed F; Joshi PP; Mohan BV; Meera R; Das MS; Ahuja RC; Saran RK; Chaturvedi V; Reddy KS
    J Am Coll Cardiol; 2009 May; 53(18):1718-28. PubMed ID: 19406349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.